top of page

Toho Pharmaceutical Co., Ltd Distribution of Detection Kits to Achieve Universal Health


According to target 3.8 UN, it is essential to achieve universal health coverage, including, access to quality essential healthcare services and access to safe, effective, quality, and affordable essential medicines and vaccines for all.[1] Coverage of essential health services includes infectious diseases and the most disadvantaged populations in the context of a pandemic of international scope.[2]


To increase diagnostic capacity in response to COVID-19 pandemic supplies and reagents that support real-time polymerase chain reaction (PCR) are needed worldwide.[3] This would help to reach the UN goal: "provide access to affordable essential medicines and vaccines for all" by 2030.[4]


TOHO HOLDINGS CO., LTD[5] has announced that its wholly-owned subsidiary, TOHO PHARMACEUTICAL CO., LTD[6]., has been entrusted with the exclusive distribution of a COVID-19 (SARS-CoV-2) detection[7] kit that will be launched by KUBIX Inc.[8]This will contribute to preventing the spread of COVID-19 and maintaining health care systems through the sale of this product[9].


As prompt detection of patients with COVID-19 symptoms is essential for patient care and isolation in designated facilities and to screen close contacts for asymptomatic infection as part of outbreak response, this will have a positive impact in the fight against Sars-CoV-2 in order to achieve universal health coverage[10].

Entradas destacadas
Vuelve pronto
Una vez que se publiquen entradas, las verás aquí.
Entradas recientes
Archivo
Buscar por tags
No hay tags aún.
Síguenos
  • Facebook Basic Square
  • Twitter Basic Square
  • Google+ Basic Square
bottom of page